Method for complex treatment of viral hepatitis D
The invention relates to medicine, namely to hepatology and therapy, and can be used for the complex treatment of viral hepatitis D.Summary of the invention consists in that on the 1st, 5th and 9th day of treatment, 200 mL of a 0.9% ozonized NaCl solution is administered intravenously, with an ozone...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; rum ; rus |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention relates to medicine, namely to hepatology and therapy, and can be used for the complex treatment of viral hepatitis D.Summary of the invention consists in that on the 1st, 5th and 9th day of treatment, 200 mL of a 0.9% ozonized NaCl solution is administered intravenously, with an ozone concentration of 6 µg/mL. On the 2nd, 4th, 6th and 8th day, 300 mL of venous blood is collected from the patient, which is ozonized, with an ozone concentration of 15 µg/mL and is transfused to the patient. On the 3rd, 7th and 10th day, intestinal insufflations are performed with an ozone-oxygen gaseous mixture in a volume of 200 mL, with an ozone concentration of 30 µg/mL. Also, daily, after each procedure, 0.5 L of ozonized drinking water is administeredper os, with an ozone concentration of 8 µg/mL. Concomitantly, one capsule is administeredper os, 15 min before meals, three times a day, for 30 days, which contains a biologically active phytotherapeutic mixture in the following ratio of components, wt.%: dry extract of amaranth seeds (Amaranthus L.) 14...16, dry extract of wormwood leaves (Artemisia absinthium L.) 8...10, dry extract of dihydroquercetin (Larix sibirica L.) 8...10, dry extract of walnut shells (Juglans regia L.) 8...11, dry extract of dandelion root (Taraxacum officinale L.) 6...8, dry extract of turmeric root (Curcuma longa L.) 7...9, dry extract of chicory root (Cichorium L.) 9...11, dry extract of leuzea root (Rhaponticum carthamoides L.) 12...15, dry extract of the aboveground part of milk thistle (Silybum marianum L.) 9...11 and glycine 5...7.
Invenţia se referă la medicină, în special la hepatologie şi terapie şi poate fi utilizată pentru tratamentul complex al hepatitei virale D. Esenţa invenţiei constă în aceea că în 1-a, 5-a şi a 9-a zi de tratament se administrează i/v, câte 200 ml de o soluţie de 0,9% de NaCl ozonată, cu concentraţia ozonului de 6 µg/mL. În a 2-a, 4-a, 6-a şi a 8-a zi se recoltează câte 300 mL de sânge venos de la pacient, care se ozonează, cu concentraţia ozonului de 15 µg/mL şi se transfuzează pacientului. În a 3-a, 7-a şi a 10-a zi se efectuează insuflaţii intestinale cu un amestec gazos de ozon-oxigen în volum de 200 mL, cu concentraţia ozonului de 30 µg/mL. Totodată, zilnic, după fiecare procedură se administreazăper os câte 0,5 L de apă potabilă ozonată, cu concentraţia ozonului de 8 µg/mL. Concomitent se administreazăper os, cu 15 min înainte de masă, de trei ori pe zi, cate o capsulă, timp de 30 de zile car |
---|